MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Olfactory dysfunction"

  • 2023 International Congress

    Olfactory sniffing is altered in patients with Parkinson’s disease

    M. Andelman-Gur, N. Hezi, A. Ezra, J. Zitser, T. Gurevich, N. Sobel (Rehovot, Israel)

    Objective: To develop an objective non-verbal non-task-dependent olfactory test for PD detection. Background: Olfactory decline may precede motor symptoms by several years or decades in…
  • 2023 International Congress

    Olfactory discrimination ability is associated with subjective lack of social support in female Parkinson’s patients

    T. Blum, L. Consortium, R. Dodel (Essen, Germany)

    Objective: We aimed to explore the relationship between olfactory discrimination ability and subjective social support in a sample of patients with Parkinson’s Disease. We hypothesized…
  • 2023 International Congress

    Normative data for the Vietnamese smell identification test

    T. Dang, K. Vo, U. Ha, Q. Ly, T. Thai, T. Nguyen, T. Tran (HO CHI MINH, Viet Nam)

    Objective: This study aimed to investigate the normative value of the VSIT in different age groups and genders Background: The Vietnamese smell identification test (VSIT)…
  • 2023 International Congress

    Olfactory dysfunction and neuropsychiatric manifestations in early drug-naïve Parkinson’s disease

    P. Julayanont (Phoenix, USA)

    Objective: To determine the severity of various neuropsychiatric disturbances in drug-naïve Parkinson’s disease (PD) patients with (PD-OD) and without olfactory dysfunction (PD-NOD) compared to healthy…
  • 2022 International Congress

    Melatonin attenuates the bidirectional Gut-Brain axis mediated inflammation caused by Ambient Particulate Matter (PM2.5) and averts neurodegeneration

    SAM. Panda, VGM. Naidu (Guwahati, India)

    Objective: To explore the therapeutic potential of melatonin in attenuating the PM2.5 induced inflammation and neurodegeneration through the Gut-brain axis in C57BL/6 mice. Background: The…
  • 2022 International Congress

    CORRELATION BETWEEN OLFACTORY DYSFUNCTION AND INTENSITY OF TREMOR

    D D. Pokhabov, V. Abramov, M. Sadovsky, D V. Pokhabov (Krasnoyarsk, Russian Federation)

    Objective: Our aim was to obtain tremor data of PD and ET patients and the results of their olfactory function, which can help verify our…
  • 2022 International Congress

    Patients with Parkinson’s Disease Share a Unique Olfactory Perceptual Fingerprint

    M. Andelman-Gur, K. Snitz, A. Ravia, N. Hezi, A. Ezra, D. Klepikov, T. Gurevich, N. Sobel (Rehovot, Israel)

    Objective: To explore potential olfactory biomarkers for early detection of Parkinson's disease Background: Although the olfactory decline in Parkinson’s disease (PD) precedes the motor symptoms…
  • 2022 International Congress

    Olfactory Network Reorganization in Parkinson’s Disease

    L. Pesantez Pacheco, M. Saqib, D. Ehrlich, M. Hallett, S. Horovitz (Bethesda, USA)

    Objective: To explore changes in the organization and functionality of the olfactory network in patients with Parkinson’s Disease (PD) using graph theory-based network analysis on…
  • 2022 International Congress

    Olfactory dysfunction in patients with Huntington disease

    J. Patino, H. Coco, S. Zadegan, S. Chandra, N. Karagas, N. Rocha, K. Anderson, A. Teixeira, E. Furr Stimming (Houston, USA)

    Objective: To investigate olfactory dysfunction (OD) in individuals with Huntington disease (HD) and its relation to disease severity. Background: HD is a hereditary neurodegenerative disease…
  • MDS Virtual Congress 2021

    Serial DaT-SPECT imaging in asymptomatic carriers of LRRK2 G2019S mutation: 8-years follow-up

    A. Sánchez Rodríguez, I. Martínez Rodríguez, M. Sierra, P. Sánchez Juan, I. González Aramburu, M. Rivera Sánchez, J. Andrés Pacheco, A. Gutiérrez-González, O. Cuenca-Vera, J. Madera, A. García-Hernández, J. Infante (Santander, Spain)

    Objective: To characterize the 8-year progression of clinical and imaging biomarkers in a cohort of asymptomatic LRRK2 G2019S carriers and to assess its utility as predictors of…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 16
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley